OPTUS Pharmaceutical Revenue

In the year 2025, OPTUS Pharmaceutical had annual revenue of 87.16B KRW with 6.42% growth. OPTUS Pharmaceutical had revenue of 22.56B in the quarter ending December 31, 2025, a decrease of -1.81%.

Revenue

87.16B

Revenue Growth

+6.42%

P/S Ratio

1.90

Revenue / Employee

548.18M

Employees

159

Market Cap

165.70B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.16B	5.26B	6.42%
Dec 31, 2024	81.90B	9.48B	13.09%
Dec 31, 2023	72.43B	13.77B	23.47%
Dec 31, 2022	58.66B	1.34B	2.34%
Dec 31, 2021	57.32B	-3.51B	-5.77%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Organoidsciences	2.41B
Kyung Dong Pharmaceutical	196.27B
PHARMARESEARCH BIO	178.19M
Vivozon Pharmaceutical	59.34B
DongKoo Bio & Pharma	242.69B
High Tech Pharm	70.18B
HYUNDAI BIOLAND	130.51B
KOREA PHARMA	87.60B

Revenue Rankings